Recent research has also demonstrated that cancer cells in a highly mesenchymal state are highly sensitive to the inhibition of GPX4 [8,9], which means that CSCs might be more susceptible to ferroptosis-inducing agents than bulk cancer cells. This evidence concerns the gene GPX4 and cancer.